Keyphrases
Adsorption Kinetics
27%
NETosis
27%
Interleukin-6
27%
Continuous Venovenous Hemodiafiltration (CVVHDF)
27%
Blood Droplet
27%
Microfluidic Assay
27%
Transpulmonary Thermodilution
27%
Differential Injection
27%
Cold Saline
27%
Return Temperature
27%
Blood Differentials
27%
Blood Return
27%
Decreased Cardiac Output
27%
Cytokine Removal
27%
Circulating Histones
27%
Disseminated mucormycosis
27%
Urinary Neutrophil Gelatinase-associated Lipocalin (uNGAL)
27%
Critically Ill Patients
27%
Polymyxin B-immobilized Fiber Column
27%
Venous Thromboembolism Prevention
27%
Management Center
27%
Antibiotic-associated Encephalopathy
27%
Cefepime Hydrochloride
27%
Chamber Structure
27%
Multicenter Observational Study
27%
Blood Type O
27%
Polymyxin B-immobilized Fiber Column-direct Hemoperfusion
27%
Hemoperfusion Therapy
27%
PMX-DHP
27%
MDA-MB-231 Cancer Cells
27%
Ionic Interaction
27%
Rectus Sheath Hematoma
27%
In Vitro Evaluation
27%
Positional Change
27%
Protein Removal
27%
Burn Patients
27%
Ubiquinone-10
27%
Continuous Hemodiafiltration
27%
Lopinavir
27%
Adult Cardiac
27%
Severe Acute Kidney Injury
27%
Lipodystrophy Syndrome
27%
Pancreatic Injury
27%
Transsylvian
27%
Insular Lesion
27%
Heschl's Gyrus
27%
Working Fluid
27%
Air Chamber
27%
Chamber Design
27%
Prismaflex
18%
Medicine and Dentistry
Acute Kidney Injury
60%
Observational Study
55%
Intensive Care Unit
35%
Hemoperfusion
32%
Blood Purification
32%
Sepsis
30%
Interleukin-6
27%
Linezolid
27%
COVID-19
27%
Brain Disease
27%
Hyperchloremia
27%
Liver Transplantation
27%
Liver Polycystic Disease
27%
Tumor Lysis Syndrome
27%
Histone H3
27%
Mucormycosis
27%
Antiinfective Agent
27%
Cohort Analysis
27%
Polymyxin B
27%
Continuous Hemodiafiltration
27%
Hemodynamic
27%
Transesophageal Echocardiography
27%
Urinary System
27%
Venous Thromboembolism
27%
Cefepime
27%
Extracorporeal Membrane Oxygenation
27%
Neutrophil Gelatinase Associated Lipocalin
27%
Myoglobin
27%
Lipodystrophy
27%
Lopinavir/Ritonavir
27%
Pancreatic Injury
27%
Continuous Renal Replacement Therapy
27%
Granulocyte
27%
Continuous Kidney Replacement Therapy
18%
Poly(methyl Methacrylate)
18%
Hemodiafiltration
18%
SOFA Score
16%
Bleeding
13%
Glycerol
13%
Blood Clotting
13%
Neutrophil
13%
Serum Chloride
12%
Highly Active Antiretroviral Therapy
12%
Pathogen Associated Molecular Pattern
11%
Infection
10%
Renal Replacement Therapy
9%
Cardiovascular Surgery
9%
Cardiopulmonary Bypass
9%
Hepatomegaly
9%
Cephalosporin Derivative
9%
Pharmacology, Toxicology and Pharmaceutical Science
Sepsis
100%
Disease
55%
Coronavirinae
55%
Septic Shock
33%
Brain Disease
27%
Lethality
27%
Muscle Weakness
27%
Epileptic Absence
27%
Burkitt's Lymphoma
27%
Thrombomodulin
27%
Cefepime
27%
Polymyxin B
27%
Hemoperfusion
27%
Triple Negative Breast Cancer
27%
Interferon Type I
27%
Lipopolysaccharide
27%
Tumor Lysis Syndrome
27%
Antiinfective Agent
27%
Lopinavir Plus Ritonavir
27%
Pancreas Injury
27%
Lipodystrophy
27%
Autoantibodies
27%
Interleukin 6
19%
Cytokine
19%
Organ Dysfunction Score
19%
Chemotherapy
16%
Infection
16%
Catecholamine
11%
Interleukin 1
11%
Pathogen Associated Molecular Pattern
11%
Adsorption
11%
Cephalosporin Derivative
10%
Inflammation
10%
Nafamstat
8%
Weakness
7%
Neurologic Disease
7%
Tipifarnib
6%
Penicillin Derivative
6%
Anuria
5%
Tumor Necrosis Factor
5%
Sodium Chloride
5%
Severe Renal Impairment
5%
Ischemia
5%
Synapsin I
5%
Endocannabinoid
5%
Survival Rate
5%
Mouse
5%
Adult Respiratory Distress Syndrome
5%
Endothelium Injury
5%
Poly(methyl Methacrylate)
5%
